Invention Grant
- Patent Title: Therapeutic agents
-
Application No.: US14085632Application Date: 2013-11-20
-
Publication No.: US09358222B2Publication Date: 2016-06-07
- Inventor: Bernard Thomas Golding , Christiane Riedinger , Roger John Griffin , Ian Robert Hardcastle , Eric Valeur , Anna Frances Watson , Martin Noble
- Applicant: CANCER RESEARCH TECHNOLOGY LIMITED
- Applicant Address: GB London
- Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
- Current Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
- Current Assignee Address: GB London
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB0811643.6 20080625
- Main IPC: C07D207/46
- IPC: C07D207/46 ; A61K31/4035 ; C07D209/48 ; C07D401/06 ; C07D403/06
Abstract:
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
Public/Granted literature
- US20140194486A1 THERAPEUTIC AGENTS Public/Granted day:2014-07-10
Information query
